Merrimack Pharmaceuticals Inc

NAS:MACK (USA)  
$ 14.76 +0.02 (+0.14%) 11:08 PM EST
At Loss
P/B:
11.27
Market Cap:
$ 214.49M
Enterprise V:
$ 195.76M
Volume:
141.65K
Avg Vol (2M):
139.05K
Volume:
141.65K
At Loss
Avg Vol (2M):
139.05K

Business Description

Merrimack Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US5903282094
Description
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.98
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 61.89
9-Day RSI 60.76
14-Day RSI 62.62
6-1 Month Momentum % 17.88
12-1 Month Momentum % 21.49

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 43.5
Quick Ratio 43.5
Cash Ratio 42.8

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.4

Financials (Next Earnings Date:2024-05-03 Est.)

MACK's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MACK

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Merrimack Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.08
Beta 0.85
Volatility % 11.82
14-Day RSI 62.62
14-Day ATR ($) 0.137403
20-Day SMA ($) 14.713
12-1 Month Momentum % 21.49
52-Week Range ($) 11.53 - 15.89
Shares Outstanding (Mil) 14.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merrimack Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Merrimack Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Merrimack Pharmaceuticals Inc Frequently Asked Questions

What is Merrimack Pharmaceuticals Inc(MACK)'s stock price today?
The current price of MACK is $14.76. The 52 week high of MACK is $15.89 and 52 week low is $11.53.
When is next earnings date of Merrimack Pharmaceuticals Inc(MACK)?
The next earnings date of Merrimack Pharmaceuticals Inc(MACK) is 2024-05-03 Est..
Does Merrimack Pharmaceuticals Inc(MACK) pay dividends? If so, how much?
Merrimack Pharmaceuticals Inc(MACK) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1